Showing results (581-590 of 2,448) with videos related to
Sort By:
Pageof 245
Depression and Anxiety|March 21, 2000
Flumazenil challenge in social phobiaN J Coupland, C Bell, J P Potokar, et al.Journal of Psychopharmacology (Oxford, England)|December 31, 2002
Effects of 5 weeks of administration of fluoxetine and dothiepin in normal volunteers on sleep, daytime sedation, psychomotor performance and moodS J Wilson, J E Bailey, C Alford, et al.Annals of the New York Academy of Sciences|March 19, 2004
BU98008, a highly selective imidazoline(1)-receptor ligandE S J Robinson, R E Price, D J Nutt, et al.Journal of Psychopharmacology (Oxford, England)|February 2, 2022
Adverse effects of psychedelics: From anecdotes and misinformation to systematic scienceAnne K Schlag, Jacob Aday, Iram Salam, et al.Psychopharmacology|January 17, 2007
A translational, caffeine-induced model of onset insomnia in rats and healthy volunteersLouise M Paterson, Sue J Wilson, David J Nutt, et al.Journal of Psychopharmacology (Oxford, England)|April 28, 2009
Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruptionL M Paterson, S J Wilson, D J Nutt, et al.Psychiatry Research|May 22, 2003
Increased sympathetic response to standing in panic disorderNick J Coupland, Susan J Wilson, John P Potokar, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 19, 2013
A translational rodent assay of affective biases in depression and antidepressant therapySarah A Stuart, Paul Butler, Marcus R Munafò, et al.International Journal of Psychiatry in Clinical Practice|June 18, 2014
Cardiovascular reflexes during treatment of social phobia with moclobemideN J Coupland Caroline Bell John P Potokar Jayne E Bailey David J NuttBjpsych Open|March 12, 2024
Medicinal cannabis for treating post-traumatic stress disorder and comorbid depression: real-world evidenceMichael T Lynskey, Alkyoni Athanasiou-Fragkouli, Hannah Thurgur, et al.Pageof 245